Does SITAGLIPTIN Cause Wrong technique in product usage process? 285 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 285 reports of Wrong technique in product usage process have been filed in association with SITAGLIPTIN (JANUVIA). This represents 1.4% of all adverse event reports for SITAGLIPTIN.
285
Reports of Wrong technique in product usage process with SITAGLIPTIN
1.4%
of all SITAGLIPTIN reports
13
Deaths
50
Hospitalizations
How Dangerous Is Wrong technique in product usage process From SITAGLIPTIN?
Of the 285 reports, 13 (4.6%) resulted in death, 50 (17.5%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Wrong technique in product usage process Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 285 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Wrong technique in product usage process?
EVOLOCUMAB (21,664)
ALBUTEROL (17,114)
ADALIMUMAB (11,766)
PEGFILGRASTIM (10,217)
ETANERCEPT (9,835)
ERENUMAB-AOOE (9,359)
SACUBITRIL\VALSARTAN (8,022)
LEUPROLIDE (5,062)
FENTANYL (2,812)
SEMAGLUTIDE (2,538)
Which SITAGLIPTIN Alternatives Have Lower Wrong technique in product usage process Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE